Metastatic alveolar rhabdomyosarcoma in multiple endocrine neoplasia type 2A

Pediatric Blood and Cancer

Volumn 55, Issue 6, 2010, Pages 1213-1216

  Jones, Ashley E ^a   Albano, Edythe A ^a   Lovell, Mark A ^a   Hunger, Stephen P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic syndrome; Medullary thyroid carcinoma; MEN 2A; Multiple Endocrine Neoplasia; Pediatric oncology; Rhabdomyosarcoma

Indexed keywords

CALCITONIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; LACTATE DEHYDROGENASE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; VINCRISTINE;

ABDOMINAL MASS; ADOLESCENT; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CANCER THERAPY; CASE REPORT; DISEASE ASSOCIATION; FAMILIAL CANCER; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEDICAL LITERATURE; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SIPPLE SYNDROME;

HUMANS; INFANT; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PROGNOSIS; RHABDOMYOSARCOMA, ALVEOLAR;

EID: 77958605441     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22591     Document Type: Article

References (20)

1. Raue F, Frank-Raue K Multiple Endocrine Neoplasia Type 2: 2007 update. Horm Res 2007; 68: 101-104.
2. Breitfeld P, Meyer W. Rhabdomyosarcoma: New windows of opportunity. Oncologist 2005; 10: 518-527.
3. Oberlin O, Rey A, Lyden E, et al. Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from United States and European Cooperative Groups. J Clin Oncol 2008; 26: 2384-2389.
4. Skinner M, Moley J, Dilley W, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005; 353: 1105-1113.
5. Winship I, Dudding T. Lessons from the skin-Cutaneous features of familial cancer. Lancet Oncol 2008; 9: 462-472.
6. Pizzo P, Poplack D, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2006. pp 17-18; 971-995.
7. Ohgaki H, Olivier M, Hainaut P. Li-Fraumeni syndrome and TP53 germline mutations. In: Louis D, Ohgaki H, Wiestler O, Cavanee W, editors. WHO Classification of Tumors of the Central Nervous System. Lyon: International Agency for Research on Cancer; 2007. pp 222-225.
8. Diller L, Sexsmith E, Gottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995; 95: 1606-1611.
9. Quezada E, Gripp K. Costello syndrome and related disorders. Curr Opin Pediatr 2007; 19: 636-644.
10. Wenger SL, Blatt J, Steele M, et al. Rhabdomyosarcoma in Roberts syndrome. Cancer Genet Cytogenet 1988; 31: 285-289.
11. Vega H, Trainer A, Gordillo M, et al. Phenotypic variability in 49 cases with ESCO2 mutations, including novel missense and codon deletion in the acetyltransferase domain, correlates with ESCO2 expression and establishes the clinical criteria for Roberts syndrome. J Med Genet 2010; 47: 30-37.
12. Meyer S, Kingston H, Taylor AM, et al. Rhabdomyosarcoma in Nijmegen Breakage syndrome: Strong association with perianal primary site. Cancer Genet Cytogenet 2004; 154: 169-174.
13. Al-Nemri AR, Kilani R, Salih M, et al. Embryonal rhabdomyosarcoma and chromosomal breakage in a newborn infant with possible Dubowitz syndrome. Am J Med Genet 2000; 92: 107-110.
14. Heney D, Lockwood L, Allibone EB, et al. Nasopharyngeal rhabdomyosarcoma and multiple lentigines syndrome: A case report. Med Pediatr Oncol 1992; 20: 227-228.
15. Digilio MC, Conti E, Sarkozy A, et al. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 2002; 71: 389-394.
16. Sobel R. Rubenstein-Taybi syndrome and nasopharyngeal rhabdomyosarcoma. J Pediatr 1981; 99: 1000.
17. Kratz C, Holter S, Etzler J, et al. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome. J Med Genet 2009; 46: 418-420.
18. Blatt J, Nakayama D. Wilms tumor associated with Hirschsprung disease. J Pediatr Hematol Oncol 2007; 29: 858-859.
19. Malek R, McCarthy-Keith D, Levens ED, et al. A gastrointestinal stromal tumor in a patient with Multiple Endocrine Neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries. Endocr Pract 2008; 14: 898-901.
20. Boedeker C, Erlic Z, Richard S, et al. Head and neck paragangliomas in Von Hippel-Lindau disease and Multiple Endocrine Neoplasia type 2. J Clin Endocrinol Metab 2009; 94: 1938-1944.